National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 23262 [E8-9285]
Download as PDF
<![CDATA[
23262
Federal Register / Vol. 73, No. 83 / Tuesday, April 29, 2008 / Notices
sroberts on PROD1PC70 with NOTICES
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Drug
Interactions.
Date: May 15, 2008.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD
20852(Telephone Conference Call).
Contact Person: Gerald L. McLaughlin,
PhD, Scientific Review Administrator,Office
of Extramural Affairs,National Institute on
Drug Abuse, NIH, DHHS,Room 220, MSC
8401,6101 Executive Blvd. Bethesda, MD
20892–8401,301–402–6626,
gm145a@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; NIDA L
Conflicts.
Date: June 2, 2008.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue,Bethesda, MD 20814.
Contact Person: Meenaxi Hiremath, PhD,
Health Scientist Administrator, Office of
Extramural Affairs,National Institute on Drug
Abuse,National Institutes of Health,
DHHS,6101 Executive Blvd., Suite 220, MSC
8401,Bethesda, MD 20892,301–402–7964,
mh392g@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; NIDA–
E Conflicts.
Date: June 4, 2008.
Time: 2:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Jurys Washington Hotel, 1500 New
Hampshire Avenue, Washington, DC 20036.
Contact Person: Jose F. Ruiz, PhD,
Scientific Review Administrator, Office of
Extramural Affairs,National Institute on Drug
Abuse, NIH,6101 Executive Blvd., Rm. 213,
MSC 8401,Bethesda, MD 20892,301–451–
3086, ruizjf@nida.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; NIDAF Conflicts.
Date: June 4, 2008.
Time: 4:30 p.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Jury Washington Hotel, 1500 New
Hampshire Avenue, Washington, DC 20036.
Contact Person: Jose F. Ruiz, PhD,
Scientific Review Administrator, Office of
Extramural Affairs,National Institute on Drug
VerDate Aug<31>2005
21:01 Apr 28, 2008
Jkt 214001
Abuse, NIH,6101 Executive Blvd., Rm. 213,
MSC 8401,Bethesda, MD 20892,301–451–
3086, ruizjf@nida.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special
Emphasis Panel; Center Review
Committee.
Date: July 21–23, 2008.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street, NW., Washington DC 20037.
Contact Person: Rita Liu, PhD, Associate
Director, Office of Extramural
Affairs,National Institute on Drug Abuse,
NIH, DHHS,Room 212, MSC 8401,6101
Executive Boulevard,Bethesda, MD 20892–
8401,301.435.1388, rliu@nida.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Program
Projects Review Committee.
Date: July 22, 2008.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street, NW., Washington, DC 20037.
Contact Person: Rita Liu, PhD, Associate
Director, Office of Extramural
Affairs,National Institute on Drug Abuse,
NIH, DHHS,Room 212, MSC 8401,6101
Executive Boulevard,Bethesda, MD 20892–
8401,301.435.1388, rliu@nida.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Center
Review.
Date: July 23–24, 2008.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street, NW., Washington, DC 20037.
Contact Person: Rita Liu, PHD, Associate
Director, Office of Extramural
Affairs,National Institute on Drug Abuse,
NIH, DHHS,Room 212, MSC 8401,6101
Executive Boulevard,Bethesda, MD 20892–
8401,301.435.1388, rliu@nida.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: April 22, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–9283 Filed 4–28–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Primary ImmunoDeficiencies.
Date: May 19, 2008.
Time: 11 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive 3121, Bethesda, MD 20817
(Telephone Conference Call).
Contact Person: Paul A. Amstad, PhD,
Scientific Review Officer, Scientific Review
Program,Division of Extramural
Activities,DHHS/National Institutes of
Health/NIAID,6700B Rockledge Drive, MSC
7616,Bethesda, MD 20892–7616,301–402–
7098, pamstad@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Helper T Cell Immunity.
Date: May 28, 2008.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD
20817(Telephone Conference Call).
Contact Person: Paul A. Amstad, PhD,
Scientific Review Officer, Scientific Review
Program,Division of Extramural
Activities,DHHS/National Institutes of
Health/NIAID,6700B Rockledge Drive, MSC
7616,Bethesda, MD 20892–7616,301–402–
7098, pamstad@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: April 22, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–9285 Filed 4–28–08; 8:45 am]
BILLING CODE 4140–01–M
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
E:\FR\FM\29APN1.SGM
29APN1
]]>Agencies
[Federal Register Volume 73, Number 83 (Tuesday, April 29, 2008)]
[Notices]
[Page 23262]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-9285]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Primary Immuno-Deficiencies.
Date: May 19, 2008.
Time: 11 a.m. to 2 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6700B Rockledge Drive
3121, Bethesda, MD 20817 (Telephone Conference Call).
Contact Person: Paul A. Amstad, PhD, Scientific Review Officer,
Scientific Review Program,Division of Extramural Activities,DHHS/
National Institutes of Health/NIAID,6700B Rockledge Drive, MSC
7616,Bethesda, MD 20892-7616,301-402-7098, pamstad@niaid.nih.gov.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Helper T Cell Immunity.
Date: May 28, 2008.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6700B Rockledge Drive,
Bethesda, MD 20817(Telephone Conference Call).
Contact Person: Paul A. Amstad, PhD, Scientific Review Officer,
Scientific Review Program,Division of Extramural Activities,DHHS/
National Institutes of Health/NIAID,6700B Rockledge Drive, MSC
7616,Bethesda, MD 20892-7616,301-402-7098, pamstad@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: April 22, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-9285 Filed 4-28-08; 8:45 am]
BILLING CODE 4140-01-M
